| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,314,909 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$7,314,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -53.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
CEO Level 15 |
• • – |
2024-02-29 |
4 |
A |
$34.43 |
$18,521 |
D/D |
538 |
174,289 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-02-16 |
4 |
S |
$44.49 |
$17,219 |
D/D |
(387) |
173,751 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-02-02 |
4 |
S |
$49.37 |
$1,160,303 |
D/D |
(23,501) |
174,138 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,788 |
197,639 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-25 |
4 |
S |
$51.75 |
$118,249 |
D/D |
(2,285) |
151,851 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-17 |
4 |
S |
$50.42 |
$1,616,319 |
D/D |
(32,059) |
154,136 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,084 |
186,195 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-21 |
4 |
S |
$49.29 |
$862,577 |
D/D |
(17,500) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-21 |
4 |
OE |
$47.34 |
$828,450 |
D/D |
17,500 |
135,611 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-20 |
4 |
S |
$49.64 |
$322,643 |
D/D |
(6,500) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-20 |
4 |
OE |
$47.34 |
$307,710 |
D/D |
6,500 |
124,611 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-14 |
4 |
S |
$49.21 |
$1,190,019 |
D/D |
(24,000) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-14 |
4 |
OE |
$47.34 |
$1,136,160 |
D/D |
24,000 |
127,251 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-10-12 |
4 |
AS |
$46.00 |
$173,420 |
D/D |
(3,770) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
CEO Level 15 |
• • – |
2023-08-31 |
4 |
A |
$30.56 |
$4,798 |
D/D |
157 |
121,881 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-07-07 |
4 |
AS |
$42.25 |
$787,953 |
D/D |
(18,650) |
121,724 |
0 |
% |
|
| CGTX |
Cognition Therapeutics In... |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-05-22 |
4 |
AS |
$40.13 |
$197,907 |
D/D |
(4,931) |
140,374 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
S |
$40.69 |
$1,003,153 |
D/D |
(24,651) |
145,305 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
49,093 |
169,956 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-01-18 |
4 |
S |
$39.49 |
$989,947 |
D/D |
(25,066) |
120,863 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,267 |
145,929 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-04-01 |
4 |
AS |
$37.49 |
$13,309 |
D/D |
(355) |
88,662 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-02-28 |
4 |
A |
$28.37 |
$17,620 |
D/D |
621 |
89,017 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
D |
$31.44 |
$252,526 |
D/D |
(8,032) |
88,396 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
